Back to the main directory
EarningsReview / Equity
- H119 results and 15 questions for management by BNP Paribas Exane
- Organic revenue growth disappoints by BNP Paribas Exane
- Greater commitment on deleveraging needed by BNP Paribas Exane
- Securitas (Buy, TP: SEK180.00) - CEO speeding up transformation by DnB Markets
- Atea (Sell, TP: NOK103.00) - SELL after share price rally by DnB Markets
- Two layers of discount unjustified by DnB Markets
- Investment Daily 08/02/2019 by BNP Paribas Exane
- FY18 preliminary results (+15 questions) by BNP Paribas Exane
- ODDO BHF Small & MIDCAP MORNING NEWS - 08/02/2019 Date Performance depuis l’entrée Date Performance depuis l’entrée by Oddo BHF
- ODDO BHF Small & MIDCAP MORNING NEWS - 02/08/2019 Date Performance since listing Date Performance since listing by Oddo BHF
- Creation of a commission of inquiry on renewable energy and the energy transition at the National Assembly: what are the risks? by Oddo BHF
- Q4/ FY18 results and 15 questions for management by BNP Paribas Exane
- FY18 results and 15 questions for management by BNP Paribas Exane
- Novo (+) rewarded, AbbVie penalised: FY18 beats and misses by BNP Paribas Exane
- Q418 results and 15 questions for management by BNP Paribas Exane
- Sparebanken Sør (Hold, TP: NOK105.00) - NII tailwind by DnB Markets
- Sparebank 1 Østlandet (Hold, TP: NOK86.00) - Costs creeping higher by DnB Markets
- Industrivärden (Hold, TP: SEK195.00) - Normalising valuation, but HOLD on by DnB Markets
- Skanska (Hold, TP: SEK155.00) - The key argument fell -27% YOY by DnB Markets
- Volatility matters (+20 questions) by BNP Paribas Exane
- Solid Start to 2019 by BNP Paribas Exane
- Feedback from marketing: scepticism over H2 recovery by BNP Paribas Exane
- Q4/FY18 results and 15 questions for management by BNP Paribas Exane
- Upside is large, but difficult to unlock by BNP Paribas Exane
- Momentum Group (Buy, TP: SEK130.00) - Building its acquisition credentials by DnB Markets
- Consistency by BNP Paribas Exane
- The day the margin guide died by BNP Paribas Exane
- Firmer long-term, but less differentiated on value by BNP Paribas Exane
- Just what the doctor ordered for the CMD by BNP Paribas Exane
- ALK-Abello (Hold, TP: DKK1125.00) - Q4 provides few surprises by DnB Markets
- AKKA Technologies : Croissance T4 2018 supérieure aux attentes et message positif sur 2019 by Oddo BHF
- AKKA Technologies : Q4 2018 growth better than expected and positive message on 2019 by Oddo BHF
- Advanced Info Service (ADVANC TB) by HSBC
- What the SRI investor should have read by BNP Paribas Exane
- Création d’une commission d’enquête sur les énergies renouvelables et la transition énergétique à l’Assemblée nationale : quels sont les risques ? by Oddo BHF
- Entra (Hold, TP: NOK125.00) - Neutral Q4, no FFO growth outlook by DnB Markets
- Q418 results (+15 questions for management) by BNP Paribas Exane
- Q4 results, and a large deal by DnB Markets
- Input costs not yet a tailwind by BNP Paribas Exane
- Credicorp (BAP US) by HSBC
- Sparebank1 SR-Bank (Buy, TP: NOK112.00) - Delivering on 2018 targets by DnB Markets
- Peab (Hold, TP: SEK79.00) - Bright spot in a cloudy sky by DnB Markets
- Husqvarna (Buy, TP: SEK90.00) - Exciting future – disappointing past by DnB Markets
- From Great to Good? by BNP Paribas Exane
- ASDA continues to chase Aldi by BNP Paribas Exane
- Strong 2018 and further growth on the horizon by BNP Paribas Exane
- EPS accretion, faster derisking and catalysts ahead by BNP Paribas Exane
- Rising ND/Americas still under-delivering by BNP Paribas Exane
- Compelling valuation but... by BNP Paribas Exane
- Bergman & Beving (Buy, TP: SEK115.00) - Forward moves in transition year by DnB Markets